This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Guler, A. Articles by Kanbak, M. Search for Related Content PubMed PubMed Citation Articles by Guler, A. Articles by Kanbak, M. Related Collections Complications Pharmacology

---

ANESTHETIC PHARMACOLOGY

Magnesium Sulfate Pretreatment Reduces Myoclonus After Etomidate

Department of Anesthesiology and Reanimation, Hacettepe University, Sihhiye Ankara, Turkey

Address correspondence to Aygun Guler, MD, Department of Anesthesiology and Reanimation, Hacettepe University, Sihhiye Ankara, Turkey 06100. Address e-mail to ayguncuhadar{at}hotmail.com.

Myoclonic movements and pain on injection are common problems during induction of anesthesia with etomidate. We investigated the influence of pretreatment with magnesium and two doses of ketamine on the incidence of etomidate-induced myoclonus and pain. A prospective double-blind study was performed on 100 ASA physical status I–III patients who were randomized into 4 groups according to the pretreatment drug: ketamine 0.2 mg/kg, ketamine 0.5 mg/kg, magnesium sulfate (Mg) 2.48 mmol, or normal saline. Ninety seconds after the pretreatment, anesthesia was induced with etomidate 0.2 mg/kg. Vecuronium 0.1 mg/kg was used as the muscle relaxant. An anesthesiologist, blinded to group allocation, recorded the myoclonic movements, pain, and sedation on a scale between 0–3. Nineteen of the 25 patients receiving Mg (76%) did not have myoclonic movements after the administration of etomidate, whereas 18 patients (72%) in the ketamine 0.5 mg/kg, 16 patients (64%) in the ketamine 0.2 mg/kg, and 18 patients (72%) in the control group experienced myoclonic movements (P < 0.05). We conclude that Mg 2.48 mmol administered 90 s before the induction of anesthesia with etomidate is effective in reducing the severity of etomidate-induced myoclonic muscle movements and that ketamine does not reduce the incidence of myoclonic movements.

This article has been cited by other articles:

				L. Huter, T. Schreiber, M. Gugel, and K. Schwarzkopf Low-Dose Intravenous Midazolam Reduces Etomidate-Induced Myoclonus: A Prospective, Randomized Study in Patients Undergoing Elective Cardioversion Anesth. Analg., November 1, 2007; 105(5): 1298 - 1302. [Abstract] [Full Text] [PDF]